SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage ...
SciSparc collaboration leads to publication of patient on binge behavior
SciSparc (SPRC) announced that as part of its ongoing collaboration with Clearmind Medicine (CMND), a biotechnology company focused on ...
American Association of Individual Investors1d
Why Mind Medicine (MindMed) Inc.’s (MNMD) Stock Is Up 10.85%
Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background. Mind ...
From ‘Just Say No’ to ‘Maybe So’? Olympia reconsiders legalizing psychedelics
The potential legalization of magic mushrooms is heading to Olympia next week as state lawmakers prepare to hear testimony on ...
justthenews5d
Oregon legislature taking up the legalization of 'magic mushrooms'
If approved, the 2025 proposals would allow for a two-year development phase before the state starts handing out licenses in ...
Q1 Earnings Forecast for MNMD Issued By Leerink Partnrs
Leerink Partnrs issued their Q1 2025 earnings per share estimates for Mind Medicine (MindMed) in a report released on ...
Leerink Partnrs Issues Negative Outlook for MNMD Earnings
Equities research analysts at Leerink Partnrs decreased their Q4 2024 earnings estimates for shares of Mind Medicine (MindMed) in a research note issued on Wednesday, January 29th. Leerink Partnrs ...
KTBS6d
From ‘Just Say No’ to ‘Maybe So’? Olympia reconsiders legalizing psychedelics
3,4-methylenedioxymethamphetamine, also known as MDMA, ecstasy or molly, which research shows to treat post-traumatic stress; and mescaline, which is found in peyote, though, both bills explicitly ...
MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.